In TSLP/OVA induced asthma model, the intranasal administration of TSLP/OVA significantly induced the elevation of serum IgE level and key inflammatory cytokines CCL17 and IL-13 levels in the lung which contributed to the disease establishment and progression. The gene discussed is IL13; the disease is asthma.